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ABSTRACT
Escherichia coli Strain Diversity in Humans:
Effects of Sampling Effort and Methodology
Emily R. Neal
Studies investigating Escherichia coli strain diversity and demographics in human
hosts are frequently inconsistent regarding sampling effort and methodology while
current strain typing methods are often expensive or laborious. To rectify these
inconsistencies, sampling effort was investigated by comparing the diversity of 15-isolate
collections to 100-isolate collections from 3 human subjects. Temporal variation in E.
coli strain diversity was also studied by collecting 15 isolates once every 6 months.
Additionally, strain identification and diversity collected by different sampling methods
(fecal swabs vs. anal swabs collected at different times around defecation) were
compared to identify any inherent biases in sampling method. This study employed
pyroprinting, a new inexpensive and simple strain typing method using pyrosequencing,
to generate DNA fingerprints (or pyroprints) based on the Intergenic Transcribed Spacer
sequences in the ribosomal RNA operon to differentiate E. coli strains. Differences in
strain diversity were apparent when comparing sampling efforts. The sampling effort
investigation suggested that certain subjects hosted very large and highly diverse E. coli
strain populations such that even 100 isolates may not fully represent E. coli strain
populations in human hosts. Instead, the sampling effort required to accurately represent
strain demographics may depend on strain richness and evenness within each host. The
temporal investigation yielded similar or greater strain abundance and diversity compared
to other typing methods in the literature suggesting pyroprinting is a similarly
discriminating tool. When agglomerated over time or by subject, no significant
differences in diversity were observed between subjects or between sampling methods
despite visible differences in strain richness and evenness.

Keywords: Escherichia coli, strain diversity, sampling effort
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CHAPTER 1
Introduction
Escherichia coli (E. coli) are generally commensal inhabitants of the mammalian
and avian gastrointestinal tract (1, 2). Because they are shed in the host feces, E. coli are
commonly used as fecal indicator bacteria (FIB) when found in environments such as
soil, resource water, or recreational water (3–5). Government agencies like the USFDA,
USEPA and state water quality control boards use E. coli counts to regulate food and
water resources (5–7) because their presence indicates fecal contamination that can carry
enteric pathogens (3, 4, 8). While pathogenic and antibiotic-resistant strains of E. coli are
heavily investigated (9–11), relatively little is known about the ecology and strain
dynamics of commensal E. coli within humans and other hosts of interest.
Because of its status as a FIB, researchers often use the E. coli species as a tool
for tracking the source of fecal contamination (5, 12, 13). Microbial source tracking
(MST) is a relatively recent and rapidly growing effort to find the sources of microbes
associated with fecal contamination. The general approach for MST identifies a particular
fecal-associated microbial species (or group of species) from the environment and
matches them to a host species (e.g. cow, human, swine, etc.) or location, based often on
host specific probes or a library-dependent set of diagnostic patterns from potential
sources (5, 13). Using E. coli for MST is only effectual because of its typically
commensal relationship with many host species. Characterizing the diversity and ecology
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of commensal E. coli is important for the use of E. coli as a suitable MST species and for
establishing the parameters (e.g. sample sizes necessary) for library-dependent MST
methods.
Variations in microbial diversity and ecology in humans are often associated with
changes in health. Several studies establish a relationship between the E. coli phylotypes
and strains present and incidence of both Crohn’s disease and inflammatory bowel
disease (IBD) (14–17). Scanlan et al. (18) found significantly lower temporal stability for
major fecal bacteria in Crohn’s disease patients compared to healthy patients, suggesting
that the temporal stability of other commensals (e.g. E. coli) may also be related to
disease onset or progression. Therefore, commensal E. coli strain presence, abundance,
and diversity may establish a healthy norm for medical comparisons, acting as a potential
indicator for general stability of the intestinal microflora.
The strain diversity of E. coli in humans is commonly evaluated using a few
isolates from many human subjects to provide a snapshot of diversity within a population
(12, 19). Very few studies describe strain diversity and stability in individual hosts (12).
Additionally, many studies only identify E. coli phylotypes (A, B1, B2, & D) (9, 19–24),
which are broad phylogenetic groups encompassing many different strains. Therefore,
more sensitive strain typing methods are required to track specific E. coli strains within a
host population.
E. coli strains are commonly differentiated using both phenotypic and genotypic
strain typing methods (5, 13). Unfortunately, the strain typing method used appears to
influence the observed strain demographics and diversity in humans (25, 26) and the
sampling effort required to accurately represent a population. In addition, studies
2

investigating temporal strain dynamics in individual hosts were inconsistent regarding
collection methods, number of isolates collected, and strain typing method used (10, 25,
27, 28, 29, 30).
Early studies by Sears et al. (27, 28) indicate one or two strains persisting over at
least a year while several less abundant strains were also detected. In these studies,
isolates from several human subjects were obtained from feces over several years and
strains were determined by antigen typing. The number of isolates collected varied with
each sampling event.
Caugant et al. (29) also found stably maintained E. coli strains in human hosts. In
this study, 550 E. coli isolates were collected from a single human subject and were
grouped into 53 strains using electrophoretic typing of 15 enzymes. Over the course of 11
months, one E. coli strain persisted for 7 months and one strain persisted for 5 months.
The number of isolates collected during each sampling event ranged from 11 to 74. While
differences between sampling techniques were investigated, the different sample types
were not taken on the same day, leaving time as a variable for change.
Anderson et al. (25) evaluated several human subjects over a seven month period
and observed a higher degree of diversity than Sears et al. This group used two different
typing methods to evaluate isolates taken from a single fecal sample from each subject
from each subject per month. Antibiotic resistance analysis (ARA) was used to type 25
isolates while ribotyping was used to type 5 isolates. Ribotyping yielded less diversity
than antibiotic resistance typing, though this could be an artifact of sampling effort. A
maximum of 31 unique antibiotic resistance profiles and 11 unique ribotypes were
observed in a single human host over the sampling period. Most strains detected by either
3

method did not persist for more than one month. However, one strain did persist for more
than five months. Though diversity comparisons between subjects were not directly
measured, the persistence results also seemed to indicate variable degrees of strain
richness and diversity across human subjects.
Lastly, Johnson et al. (10) investigated E. coli persistence and sharing between six
household members (including one dog) using rapid amplified polymorphic DNA
(RAPD) analysis and pulse field gel electrophoresis (PFGE) to identify strains. Five
isolates were collected from six fecal samples from each subject over a three year period.
Only a total of 14 E. coli strains were identified in the entire three-year study from which
extensive strain sharing was observed between all household members. Certain strains
persisted in human subjects up to almost three years. In a similar study, Damborg et al.
(30) investigated E. coli strain diversity in 18 human subjects over six months and
reported strains shared within a household commonly persist in individuals for over six
months. E. coli isolates were collected using either rectal or fecal swabs from subjects
grouped in 8 households. Only a maximum of ten isolates collected over the entire six
months from each subject were analyzed using amplified fragment length polymorphism
(AFLP). In general, the investigation found high diversity over the six months detecting
an average of six strains per ten E. coli isolates. The data presented did not report any
impact of the different sampling methods used. Because subjects in both the Johnson and
Damborg studies were members of the same households, strains could have been reacquired between housemates rather than persisting in an individual.
Overall, the existing temporal studies in the literature review were inconsistent in
the number of isolates collected per sampling event. Inconsistencies not only prevent
4

direct diversity comparisons between sampling events but may also lead to some
samplings in which only dominant strains are detected and other samplings in which
minor strains can also be detected. Additionally, many of these studies lacked evidence
supporting the level of sampling effort used to investigate strain dynamics. The number
of isolates necessary for representative sampling has not been investigated for any strain
typing method to date. Studies in the literature collected isolates from either feces or
anal-rectal swabs, but analysis of differences between sampling strategies was limited to
the detection of a particular strain or strain characteristic, usually related to pathogenicity
(31–34).
To rectify this lack of information regarding the diversity of commensal E. coli
and clarify inconsistencies in the literature, we investigated E. coli strains using a new
genotypic strain typing method called pyroprinting described by Black et al. (unpublished
35, 36). Fifteen isolates were collected from fecal samples once a month for six months.
Sampling effort was also investigated by comparing collections of 100 E. coli isolates to
collections of 15 isolates taken at the same time. In addition, this study is the first to
analyze the effects of sampling method on observed commensal E. coli strain diversity
and detection in humans.

5

CHAPTER 2
Methods and Materials

Study Design and Sampling
Samples were collected from three human subjects once a month for a total of six
months. Subject B (male) was age 21-22 over the course of the study; subjects A and C
(females) were ages 25 and 20-21, respectively. During one sampling event, different
methods were used to collect E. coli: 1) an anal swab directly before defecation, 2) an
anal swab immediately after defecation prior to wiping, 3) an anal swab several hours
later post-defecation, and 4) a swab from the homogenized fecal sample collected for
that day (Fig. 1).
Swabs were immediately streaked on MacConkey agar and taken to the lab for
processing within 24 hours. Streaked plates were stored at 4°C if necessary prior to an
overnight incubation at 37°C. Fifteen isolates from each original MacConkey plate were
selected for further investigation. To address questions regarding sampling effort, 100 E.
coli isolates were collected from homogenized fecal samples on month 1 and month 6 for
each subject. Approximately three to five grams were diluted in sterile water to a
concentration of 100 mg feces•ml-1. Dilutions of 10-2, 10-3, and 10-4 mg•ml-1 were plated
on MacConkey agar, and isolates were selected for confirmation.

6

Figure 1. Sampling Plan for Subject A. Letters represent sampling method where D = diluted stool
samples, F = fecal swab, B = before swab, I = immediate swab, and L = later swab. The sampling strategy
described in month 2 for subject A was exactly the same for subjects B and C except the month selected for
different sampling methods. Month 1 was selected for subject B, and month 4 was selected for subject C.

E. coli Confirmation.
MacConkey agar was used as the initial isolation step. To ensure pure cultures,
pink colonies selected from the first MacConkey plate were streaked onto MacConkey a
second time. From this second plate, pink colonies were streaked onto Luria-Bertani (LB)
agar. Isolates on LB were confirmed as E. coli if they: 1) produced a green metallic
sheen on eosin-methylene blue agar, 2) produced indole in tryptone broth, and 3)
remained negative for growth on Simmons’ citrate agar.
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Pyroprinting
The method described by Black et al. (unpublished 35) was used for this study.
Specifically, two separate colony PCR reactions amplified each of two genomic
intergenic transcribed spacer regions (ITS1 and ITS2) using flanking primers described in
Black et al (unpublished). Gel electrophoresis (2.5% agarose in Tris-acetic acid-EDTA
buffer) confirmed PCR success. PCR products were processed for pyrosequencing with a
Qiagen Pyromark® Q24 using dispensation sequences established in Black et al
(unpublished 35). A pyroprint is defined as the ordered list of light-emission peak heights
for each nucleotide dispensation in a sequencing reaction. Pyroprint data were exported
from the Pyromark® software and collected for pairwise similarity analysis.

Statistics
Pyroprints for the same ITS regions were compared between different E. coli
isolates using Pearson’s correlation to assess similarity. For clarification, at the end of
this analysis two correlation matrices were produced: one comparing pyroprints from
ITS1 for all isolates and another comparing pyroprints from ITS2 for the same isolates. A
novel algorithm was developed for clustering isolates into strains using correlation values
between isolates from both ITS regions (35–37). For this study, the algorithm was
customized such that subject and sampling time were considered when clustering (37).
Isolates collected within a subject were clustered first at month 1, then month 2, and so
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on. This process was completed for all three subjects, and only then were clusters
compared across subjects.
The Shannon-Weaver index and Pielou’s evenness were calculated for every
sample type collected during each sampling event from each subject. Diversity indices
were used to compare temporal diversity and strain diversity identified by the different
sampling methods. One-way repeated measures analysis of variance was performed using
Minitab® 16 to compare Shannon-Weaver values and evenness between subjects across
all six months and between sampling methods (B, F, I, L) across all subjects.
The Freeman-Halton version of Fisher’s exact test was used to compare the
distribution of strains identified from the dilution samples and fecal swab samples
collected together at the same times. This test was conducted six times using the FREQ
procedure in SAS 9.2: one for each sampling event (month 1 and month 6) from all
subjects (A, B, and C).
To compare the dilution sampling effort to the fecal swab sampling, rarefaction
curves were generated for the same six data sets (described above), EstimateS (38) was
used to calculate the number of strains observed (Sobs) with the Mao Tau analytical
method. Data were exported and graphed using Microsoft® Excel 2010.
To assess similarity of sampling methods the frequency of detection across all
sampling methods in a given strain was compared using binary logistic regression. Data
from each subject were analyzed separately in Minitab® 16, and binary logistic
regression was applied for each strain.
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CHAPTER 3
Results

Effects of Sampling Effort
Strain distributions from dilutions (100 isolates) and fecal swabs (15 isolates)
were compared for month 1 and month 6 in all 3 subjects (Fig. 2). Differences in strain
distribution across sampling efforts (100 vs. 15 isolates collected) were assessed using
Fisher’s exact tests. No significant differences in strain distribution were found between
the samples collected from subject A (both month 1 and month 6) and between the
samples from subject B at month 6 (P values > 0.05). All other comparisons showed a
significant difference in the distribution of strains between the two levels of sampling
effort.
Rarefaction curve trajectories measuring number of strains sampled using fecal
swabs more closely followed curve trajectories generated from the dilution samples (Fig.
3C, E, F) when the distributions of strains between the two were found to be significantly
different. Alternatively, when the distribution of strains was not found to be significantly
different, the fecal swab rarefaction curves displayed greater curvature than the dilution
sample rarefaction curves (Fig. 3A, B, D). In these cases, the fecal swabs detected fewer
strains than dilutions for the same number of collected isolates. For example, the fecal
swab from subject B month 6 was predicted to detect a total of 6 strains using 13 isolates
10

whereas the dilution would detect 10 strains using 13 isolates (Fig. 3D). Although
dilution rarefaction curves generated from subject A month 6 (Fig. 3B), subject B month
1 (Fig. 3C), and subject C month 1 (Fig. 3E) displayed less curvature than the other
dilution rarefaction curves, none of the curves for either sampling type reached an
asymptote for number of identified strains indicating that neither 15 nor 100 isolates were
sufficient to detect the majority of strains present in the fecal samples.

Figure 2. Sampling Effort Distribution Comparisons. Percentage of total isolates collected from a
particular sampling method (stool dilution or fecal swab) represented by each strain detected for all three
human subjects A, B, & C from month 1 (M1) or month 6 (M6). Strains detected at less than 10% of the
total isolates collected from the dilution were categorized together in each figure unless the strain was
detected again from the fecal swabs (e.g. strain 32 from subject B M1). * indicates significant differences
(P < 0.05).
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Figure 3. Sampling Effort Rarefaction Curves. Rarefaction curves were generated using the Sobs calculated
with the Mao Tao method for each sampling effort event conducted. All subjects were sampled at month 1
and month 6. Different numbers of E. coli were isolated using the two methods: Dilution (100 isolates) and
Fecal (15 isolates).

In general, a majority of isolates collected from fecal swabs (15 isolates total)
represented strains that were also isolated from fecal dilutions (100 isolates). In the best
case, 100% of the isolates from subject A at month 1 were represented in the
12

corresponding dilution sample, while in the worst case only 38% of the isolates from
subject C at month 6 were represented in the dilution sample (Table 1). Perhaps
unsurprisingly, these two extremes in representation across sampling effort correlate to
extremes in strain diversity (Fig. 2).
Table 1. Sampling Effort Strain Representation
Number of strains detected from both fecal swabs and dilution samples from Months 1 and 6 and percent of
strains from fecal swabs represented in the dilution sample.
Month 1
Month 6
No. of F
No. of F
No. of F
No. of D
No. of F
No. of D
strains in D
strains in D
Subject
strains
strains
strains
strains
(%)
(%)
A
3
20
3 (100.0)
3
18
2 (66.7)
B
5
16
4 (80.0)
6
24
4 (66.7)
C
5
15
3 (60.0)
8
32
3 (37.5)
Letters represent subject (A-C) or sample type (F and D) as described in Methods and Materials.
Table displays both the number of strains and percentages of strains detected using fecal swabs that were
also detected in dilution samples.

Effects of Sampling Method
Average Shannon-Weaver values for each sampling method were calculated using
data from all three subjects and compared using repeated measures ANOVA. No
significant differences were observed between sampling methods (Fig. 4A). The test was
repeated using Pielou’s evenness values, and again no significant differences were
observed between mean evenness values of each sampling method (Fig. 4B). However,
large variability around the means was observed except in the evenness of strains from
swabs taken before defecation.
Data from different swab samples collected during a single sample month (Fig. 1)
were analyzed using binary logistic regression to test the hypothesis that sampling
method does not affect strain detection. If this were true then each strain would have an
13

equal chance of detection by each sampling method, that is, a particular strain should not
be represented by isolates from predominantly one sampling method. Binary logistic
regression requires at least three isolates in each strain to determine significant
differences (P < 0.05); therefore not all strains detected by the sampling methods could
be analyzed.
A) Shannon-Weaver

B) Pielou’s Evenness

2.5

2.5

2

2

1.5

1.5

1

1

0.5

0.5

0

0

Subject A
Subject B
Subject C
Average

Figure 4. Sampling Method Shannon-Weaver and Pielou’s Evenness. A) Shannon-Weaver values from
each subject and the average values calculated using all three subjects for every sampling method. No
significant differences were found between the averages (P >0.05). B) Pielou’s evenness values calculated
for every sampling method from each subject and the average values calculated using all three subjects. No
significant differences were found between the sample types (P >0.05)

Between two and six strains from each subject were detected in significantly
higher proportions by one or two sampling methods, but the proportions of strains with
three or more isolates varied by subject (Fig. 5). Seven of the 16 strains collected from
subject A were represented by 3 or more isolates while only 2 of these (29%) were
detected in significantly different proportions by sampling method. In subject B, 9 out of
22 strains were represented by more than 3 isolates, and 4 of these (44%) were detected
in significantly different proportions. Subject C held the extreme with 6 out of 24 strains

14

Figure 5. Strains Identified by Sampling Method. Strains identified using the four different sampling
methods and analyzed using binary logistic regression. * identifies strains with a p-value less than α = 0.05,
indicating sampling methods used to detect a particular strain were disproportionately represented.
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represented by more than 3 isolates, and all 6 (100%) were detected in significantly
different proportions by sampling method.

Temporal strain diversity and stability
Isolates collected from fecal swabs over six months were used for temporal
comparisons (Fig. 6 & 7). Subject A had the fewest total strains isolated over the study.
Subjects B and C had more similar numbers of strains detected, although the largest
number of strains were isolated from C (Table 2).
9

Number of Strains

8
7

Subject A

6

Subject B

5

Subject C

4
3
2
1
0
Month 1 Month 2 Month 3 Month 4 Month 5 Month 6

Figure 6. Numbers of Strain Detected Monthly. Number of strains detected from each subject in each of
six months using F swab samples.

To compare temporal diversity between subjects, Shannon-Weaver index and
Pielou’s evenness values were calculated for each sampling event and then averaged for
each subject (excluding month 4 for subject A). Although no significant differences were
observed between subjects (P > 0.05), both diversity indices were lowest from subject A
suggesting less strain diversity, while subjects B and C both had higher and more similar
values of diversity (Table 2).
16

Table 2. Temporal Strain Diversity for Each Subject
Average strain detection and diversity measurements over the six month study period
Subject
Average number of strains
Shannon index
Pielou’s evenness
(total strains detected) detected per month (Min-Max)
A (15)
3.17* (≤1-6)
0.93 (± 0.44) a
0.69 (± 0.17) a
B (25)
6
(4-8)
1.56 (± 0.32) a
0.88 (± 0.08) a
C (29)
6.67
(5-9)
1.59 (± 0.42) a
0.84 (± 0.12) a
*Average for subject A calculated using all 6 months, including month 4 in which zero E. coli were
detected. As this is a descriptive study and the subject did not host E. coli at detectable levels, the study
aims to present realistic observations which could be applicable to other normal human
individuals/populations. The average number of strain collected during months only in which E. coli were
collected was 3.8.

Within all three subjects, the majority of strains were detected only once during
the six-month study period (Fig. 7 & 8). No strains were detected in more than two
sampling events from subject A, indicating low strain stability. Low strain stability was
also observed in subject C, who had the highest percentage of strains detected in only one
sample (Fig. 8). Interestingly, subject C also had the highest percentage of strains
detected in four out of six samples, which indicates high strain stability. Strains detected
multiple times, however, were not necessarily detected in consecutive months. For
example, strain 33 was detected in months 1, 2, 4, and 5 from subject B but did not
appear in month 3 (Fig. 7B). In month 4, no E. coli were detected from subject A (Fig.
6). Colonies appearing on MacConkey agar from that month were identified as
Salmonella sp. after analysis using API-20E® strips (data not shown).
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Figure 7. Temporal Strain Persistence. Persistence of each strain detected using F sampling from each
subject during the six month study.

No formal log was kept regarding subjects’ diets and daily health, but major
events were recorded. Most notably, subject A traveled between the month 2 and month 3
collections and experienced a day of diarrhea approximately two weeks before the month
18

4 collection. These events coincide with changes in the E. coli strains detected and a lack
of strain persistence in subject A. Two strains were detected from both month 1 and
month 2 collections, but after traveling, three different strains appeared at month 3. After
the intestinal disruption in month 4, two new strains appeared and persisted through
months 5 and 6 (Fig. 7A). Subject B reported consuming antibiotics several weeks prior
to the first collection date and experienced gastroenteritis that delayed collection from
month 4. However no obvious impacts to stability were apparent as half of the strains
detected in month 3 were also detected in month 4. Subject C recorded no major health
changes but did note that collections during months 4-6 occurred immediately following
menstruation. This coincided with an increase in the number of strains detected during
those three months (Fig. 7C).

Figure 8. Frequency of Strain Detection. Frequency with which strains were detected for each subject.
Data are represented as percentages of the total number of strains detected over six months from F swab
samples and the frequency with which a certain percentage of strains were detected. Detecting a strain
more than once does not necessarily imply consecutive detection. For example, strain 34 isolated from
subject C was detected in month 1 and only again in month 5.
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E. coli Abundance and Strain Distribution among Subjects
The number of strains isolated and characterized was a small fraction of the total
E. coli present in each subject. Fecal samples taken at months 1 and 6 produced counts of
E. coli around 107- 108 CFU•g-1 feces from all 3 subjects. These concentrations are
consistent with other studies (2, 39). Therefore, the largest samplings (100 isolates at
months 1 and 6) represent only 0.001% of the total E. coli in 1 gram of feces. Over the
course of the six-month study, a total of 962 E. coli isolates were collected, confirmed,
pyroprinted and found to comprise 153 different strains. Subject A hosted the fewest
strains, followed in increasing order by subjects B and C (Table 3). The majority of
strains were unique to 1 subject while 14 (9.2%) were shared by at least 2 subjects and
only 4 strains (2.6%) were shared by all 3 subjects. Subjects A and C shared the most
strains (Tables 3 and 4). The most dominant strain (that is, the strain comprised of the
most E. coli isolates among the isolates sampled) also was shared by all 3 subjects (strain
9, Table 4). No other correlation between strain dominance and sharing was apparent in
the data.

Table 3. Quantity of Detected Strains from All Collected E. coli per Subject
Subject
Total no. of strains
No. of unique strains*
Percentage shared strains**
A
50
38
24.0
B
56
49
12.5
C
66
53
19.7
*Unique strains are defined in this case as strains detected from only one subject or, not shared by subjects
**Percentage includes strains shared by one or two other subjects divided by the total number of strains
detected from that subject.
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Table 4. Shared Strains between Subjects
Number of E. coli strains shared between subjects and number of contributing isolates* from each subject.
Number of Isolates by Subject
Total
Shared Strains
Isolates
A
B
C

Two
Subjects

Three
Subjects

Strain 11
Strain 12

2
18

-

7
8

9
26

Strain 29

4

-

3

7

Strain 30

3

-

2

5

Strain 31

1

-

5

6

Strain 97

1

-

1

2

Strain 110

1

-

2

3

Strain 27

2

1

0

3

Strain 54

-

2

1

3

Strain 88

-

1

3

4

Strain 9
Strain 10

51
5

4
2

27
11

82
18

Strain 22

21

1

2

24

Strain 39

1

1

1

3

Total
14 Strains
110
12
73
195
*The number of contributing isolates represents the total number of isolates from the indicated subject
contributing to all strains shared by subjects indicated in column
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CHAPTER 4
Discussion

Pyroprinting as a Strain Typing Method
A bacterial strain is defined based on the typing method used to differentiate
isolates beyond the species level (12). For example, E. coli strains were originally defined
as isolates with the same surface antigens identified through serological typing (27, 40).
However, worldwide collections of enterotoxigenic E. coli are differentiated by only a
few serotypes. As newer, more discriminating typing methods were introduced, the E.
coli strains they defined were better differentiated. As a result, literature estimates of
strain diversity within a host have generally increased over time (12). The current gold
standard for strain-level analysis of E. coli is multi-locus sequence typing (MLST) where
gene sequences from 7 different housekeeping genes are compared together (41). MLST
can differentiate between strains derived from the same parent clone over very short
evolutionary periods (41). However, this method is neither rapid nor cheap, making the
analysis of large numbers of isolates difficult. This is the first large-scale use of a new
method for typing E. coli strains in human hosts and a comparison to existing literature
values for strain diversity and richness serves to calibrate pyroprinting in relation to other
methods.
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E. coli strain diversity and richness among this study’s subjects parallel results
from previous studies using single enzyme ribotyping, ARA, and AFLP strain typing
methods. Anderson et al. (25) generated average strain accumulation curves from five
human subjects using both ribotyping and ARA to analyze 45 and 15 collected isolates,
respectively. Anderson et al. detected approximately 3 different ARA-defined strains
using 45 isolates and approximately 2 different ribotype-defined strains using 15 isolates.
Rarefaction curves generated in our study indicate pyroprinting can discriminate more
strains in both small 15 isolate sampling efforts (3-8 strains) and large 100 isolates
sampling efforts (15-32 strains). Over 7 months, Anderson et al. identified between 3 and
11 strains per subject with ribotyping (analyzing 35 total isolates per subject) and
between 21 and 33 strains per subject with ARA (analyzing 175 total isolates per
subject). Over 6 months, Damborg et al. (30) identified between 1 and 10 strains per
subject using AFLP, although only 10 isolates were collected from each subject over the
entire length of the study. Over 6 months, our study identified between 15 and 29 strains
per subject using pyroprinting to analyze 90 isolates per subject. The results between
similar sampling efforts and temporal analyses from this study and the others mentioned
provide evidence that pyroprinting may be more discriminating than single enzyme
ribotyping and ARA. The sampling effort in Damborg et al. is not sufficient to compare
pyroprinting to AFLP.
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Effect of Sampling Effort
One hundred isolates were sampled twice from all three subjects with the
assumption that this sampling effort would accurately represent the E. coli strains present
at the time of sampling. Other studies using genotypic methods suggest sampling 15
isolates would represent a majority of strain diversity actually present in the host (25, 26).
Lautenbach et al. (26) suggested strains comprising only 5% of the population are likely
to be sampled 50% of the time if 15 isolates are collected and analyzed using PFGE.
However, we observed significant differences in the distribution of strains, as well as
differences in strain representation, between the 100 isolate dilution samples and the 15
isolate fecal swabs. In some cases, strains detected using 15 isolates were not detected
when 100 isolates were collected (Fig. 2). These results indicate a large and diverse
collection of E. coli strains is present in human hosts. We sampled at most 0.001% of the
total E. coli population present in one gram of feces. A human may host many E. coli
strains (high strain richness) in relatively equal proportions (high evenness). Under these
circumstances many strains will have equal probability for detection, requiring a
relatively large sample size to accurately represent the diversity within a population of E.
coli strains. Alternatively, low strain richness and/or evenness would allow a smaller
sample size to accurately represent strain diversity within the host. If richness is high but
evenness is very low in the population, a small sample size will likely represent the most
abundant strains but will miss detection of the more rare strains.
This interplay between richness, evenness, and diversity can be observed in the
strain distribution graphs (Fig. 2) and rarefaction curves (Fig. 3). No significant
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differences were found between the distributions of strains in three cases (Fig. 2 AM1,
AM6, BM6); yet in these cases the rarefaction curves for the two levels of sampling
effort deviate in curvature (Fig. 3A, B, D). This is consistent with an E. coli strain
population of high richness and low evenness where the most abundant strains are easily
detected in both sampling efforts (Fig. 2). In addition, this high richness, low evenness
scenario implies a large number of rare strains are more likely detected with a large
sampling effort while being missed with a small sampling effort. Thus, the small sample
size displays greater curvature than the large sample size curve (Fig. 3A, B, D).
Conversely, a high richness, high evenness scenario will result in different distributions
(Fig. 2 BM1, CM1, CM6) yet similar rarefaction curves when comparing small and large
sampling efforts because all major strains are equally likely to be detected. In
concordance, both rarefaction curves display similar curvature and indicate a much larger
sample size would be necessary to accurately determine strain richness (Fig. 3C, E, F).
Very few studies collect 100 or more E. coli isolates from a single human subject,
yet many still draw conclusions regarding the diversity of E. coli strains within a given
human host. The Anderson et al. (25) accumulation curves displayed high curvature
suggesting that the sample sizes selected for ARA and ribotyping in that study adequately
represented actual strain richness. However, rarefaction curves from subject A in our
study displayed similar curvature for smaller 15 isolate samples sizes as the ARA (45
isolates) and ribotype (15 isolates) curves yet lower curvature using larger 100 isolate
samples. Thus, subjects in the Anderson et al. investigation may have hosted strains with
low evenness such that rare strains were not detected using only 15 isolates collected for
ribotyping and increased strain diversity might have been observed with a larger
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sampling effort. Additionally, the high curvature appearinging with a greater number of
isolates collected for ARA also suggests the subjects hosted strains with low evenness. It
is also possible that ARA ultimately is not a very discriminating strain differentiation
method. Unfortunately, since E. coli strain diversity can vary between human subjects,
the sample size necessary to accurately detect and represent E. coli strains may depend on
the individual subject. Thus, larger sample sizes of collected E. coli isolates from
multiple hosts are necessary to accurately estimate richness and diversity. This poses a
dilemma for the design and scope of diversity investigations and will likely impact
estimates of sharing and persistence among hosts as well as comparisons of sampling
methods.

Effects of Sampling Method
The four sampling methods tested in this study yielded significantly different
proportions of some E. coli strains from the same subject when 15 strains were analyzed
from each sample (Fig. 5). This could be a result of inherent biases in the sampling
methods. For example, anal swabs might over-sample E. coli strains colonizing locations
near the sampling site while strains collected from the feces could be colonizing sites
along the entire length of the colon. The timing of anal swab sampling with respect to
defecation might also affect strain representation in a sample since fecal material may
deposit new strains near the sampling site, which could later die off. However, since fecal
samples were homogenized before swabbing or dilution, position within a fecal discharge
should not have affected strain representation in these samples.
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Alternatively, a highly rich and evenly distributed assemblage of strains could
produce the observed results by random chance due to insufficient sampling effort. For
example, more richness and high evenness was measured from subject C, and almost no
strains were detected by more than one sampling method (Fig. 5C) possibly due to a
similar detection probability of the many strains present in this host. In contrast, the least
diverse and least even E. coli population was measured from subject A. This may explain
why, even though only 15 isolates were collected using each sampling method, subject A
was the only host from which a strain was detected using all four methods (Fig. 5A).
Because sampling effort may have confounded the methods investigation, no clear
evidence exists for differences between sampling methods and no conclusions can be
made.
Sampling method did not significantly impact diversity or evenness measured
across the subjects. However, average diversity and evenness values contained large
variability except in the evenness of strains from swabs taken before defecation.
Additionally, only three subjects participated in this study. Because of the small sample
size and large variability that may have masked true differences, we cannot conclude that
sampling method had no effect on detected strain diversity or evenness.
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Sharing of E. coli Strains between Hosts
Little strain sharing was observed between the subjects in this study even though
strain diversity was high within individuals. However, the host sample size in this study
was small and may not represent the actual amount of strain sharing in a human
population. Future studies should be conducted using pyroprinting to collect E. coli from
larger human populations. If humans do not share many E. coli strains with each other
this would suggest that either E. coli are not ideal candidates for microbial source
tracking or very large databases are needed for library-dependent MST to track human
contributions to E. coli strains present in the environment.

Strain Diversity and Stability
Although differences in diversity were apparent in the subjects over the course of
the study, they were not statistically significant based on the diversity indices used to
characterize the E. coli strain assemblages. Again, average diversity and evenness values
contained large variability, possibly due to sampling effort or variation in strain stability
between sampling events, that may have masked true differences in diversity.
Though it is difficult to relate the specific results of this study to concrete
conclusions regarding subject health and temporal strain stability, the results seem to
compliment other studies regarding the stability of the intestinal microflora from
unhealthy patients since the subject reporting more intestinal unrest also exhibited the
least temporal stability of E. coli strains. Additional use of pyroprinting may continue to
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lend new and supportive evidence for using E. coli as an indicator for general intestinal
health. E. coli of the B2 phylogroup are more frequently associated with intestinal
disorders such as CD and IBD (14–17). Since the observations of this study correlate host
environment, travel, and menstruation with changes in both strain diversity and temporal
stability, observed microflora diversity should be considered along with other host
variables before making generalized conclusions regarding human health.

29

LIST OF REFERENCES

1.

Shulman ST, Friedmann HC, Sims RH. 2007. Theodor Escherich: the first
pediatric infectious diseases physician? Clin. Infect. Dis. 45:1025 –1029.

2.

Tenaillon O, Skurnik D, Picard B, Denamur E. 2010. The population genetics of
commensal Escherichia coli. Nat. Rev. Microbiol. 8:207–217.

3.

Ishii S, Sadowsky MJ. 2008. Escherichia coli in the environment: implications for
water quality and human health. Microbes Environ. 23:101–108.

4.

Meays CL, Broersma K, Nordin R, Mazumder A. 2004. Source tracking fecal
bacteria in water: a critical review of current methods. J. Environ. Manage. 73:71–
79.

5.

Simpson JM, Santo Domingo JW, Reasoner DJ. 2002. Microbial Source
Tracking: state of the science. Environ. Sci. Technol. 36:5279–5288.

6.

Feng P, Weagant SD, Grant MA. September 2002, posting date. Chapter 4,
Enumeration of Escherichia coli and the coliform bacteria. In Bacteriological
Analytical Manual. FDA. http://www.fda.gov/Food/FoodScienceResearch/
LaboratoryMethods/ucm064948.htm.

7.

USEPA. 2002. Method 1603: Escherichia coli (E. coli) in water by membrane
filtration using modified membrane-thermotolerant Escherichia coli agar (modified
mTEC). USEPA, Washington, DC. http://www.epa.gov/nerlcwww/documents/
1603sp02.pdf

8.

Casarez EA, Pillai SD, Di Giovanni GD. 2007. Genotype diversity of Escherichia
coli isolates in natural waters determined by PFGE and ERIC-PCR. Water Res.
41:3643–3648.

9.

Bailey JK, Pinyon JL, Anantham S, Hall RM. 2010. Commensal Escherichia coli
of healthy humans: a reservoir for antibiotic-resistance determinants. J. Med.
Microbiol. 59:1331–1339.

10. Johnson JR, Clabots C, Kuskowski MA. 2008. Multiple-host sharing, long-term
persistence, and virulence of Escherichia coli clones from human and animal
household members. J. Clin. Microbiol. 46:4078–4082.

30

11. Le Gall T, Clermont O, Gouriou S, Picard B, Nassif X, Denamur E, Tenaillon
O. 2007. Extraintestinal virulence is a coincidental by-product of commensalism in
B2 phylogenetic group Escherichia coli strains. Mol. Biol. Evol. 24:2373–2384.
12. Gordon D. 2010. Strain typing and the ecological structure of Escherichia coli. J.
AOAC Int. 93:974–984.
13. Scott TM, Rose JB, Jenkins TM, Farrah SR, Lukasik J. 2002. Microbial source
tracking: current methodology and future directions. Appl. Environ. Microbiol.
68:5796–5803.
14. Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, Orsi
RH, Wiedmann M, McDonough P, Kim SG, Berg D, Schukken Y, Scherl E,
Simpson KW. 2007. Culture independent analysis of ileal mucosa reveals a
selective increase in invasive Escherichia coli of novel phylogeny relative to
depletion of Clostridiales in Crohn’s disease involving the ileum. ISME J.
1:403–418.
15. Kotlowski R, Bernstein CN, Sepehri S, Krause DO. 2007. High prevalence of
Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel
disease. Gut. 56:669–675.
16. Martinez-Medina M, Aldeguer X, Lopez-Siles M, González-Huix F, López-Oliu
C, Dahbi G, Blanco JE, Blanco J, Garcia-Gil LJ, Darfeuille-Michaud A. 2009.
Molecular diversity of Escherichia coli in the human gut: new ecological evidence
supporting the role of adherent-invasive E. coli (AIEC) in Crohn’s disease.
Inflamm. Bowel Dis. 15:872–882.
17. Petersen AM, Nielsen EM, Litrup E, Brynskov J, Mirsepasi H, Krogfelt KA.
2009. A phylogenetic group of Escherichia coli associated with active left-sided
inflammatory bowel disease. BMC Microbiol. 9:171.
18. Scanlan PD, Shanahan F, O’Mahony C, Marchesi JR. 2006. Cultureindependent analyses of temporal variation of the dominant fecal microbiota and
targeted bacterial subgroups in Crohn’s disease. J. Clin. Microbiol. 44:3980–3988.
19. Escobar-Páramo P, Le Menac’h A, Le Gall T, Amorin C, Gouriou S, Picard B,
Skurnik D, Denamur E. 2006. Identification of forces shaping the commensal
Escherichia coli genetic structure by comparing animal and human isolates.
Environ. Microbiol. 8:1975–1984.
20. Duriez P, Clermont O, Bonacorsi S, Bingen E, Chaventré A, Elion J, Picard B,
Denamur E. 2001. Commensal Escherichia coli isolates are phylogenetically
distributed among geographically distinct human populations. Microbiol.
147:1671–1676.

31

21. Escobar-Páramo P, Grenet K, Le Menac’h A, Rode L, Salgado E, Amorin C,
Gouriou S, Picard B, Rahimy MC, Andremont A, Denamur E, Ruimy R. 2004.
Large-scale population structure of human commensal Escherichia coli isolates.
Appl. Environ. Microbiol. 70:5698–5700.
22. Gordon DM, Bauer S, Johnson JR. 2002. The genetic structure of Escherichia
coli populations in primary and secondary habitats. Microbiol. 148:1513 –1522.
23. Gordon DM, Stern SE, Collignon PJ. 2005. Influence of the age and sex of human
hosts on the distribution of Escherichia coli ECOR groups and virulence traits.
Microbiol. 151:15–23.
24. Gordon DM, Clermont O, Tolley H, Denamur E. 2008. Assigning Escherichia
coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR
triplex method. Environ. Microbiol. 10:2484–2496.
25. Anderson MA, Whitlock JE, Harwood VJ. 2006. Diversity and distribution of
Escherichia coli genotypes and antibiotic resistance phenotypes in feces of humans,
cattle, and horses. Appl. Environ. Microbiol. 72:6914–6922.
26. Lautenbach E, Bilker WB, Tolomeo P, Maslow JN. 2008. Impact of diversity of
colonizing strains on strategies for sampling Escherichia coli from fecal specimens.
J. Clin. Microbiol. 46:3094–3096.
27. Sears HJ, Brownlee I, Uchiyama JK. 1950. Persistence of individual strains of
Escherichia coli in the intestinal tract of man. J. Bacteriol. 59:293–301.
28. Sears HJ, Brownlee I. 1952. Further observations on the persistence of individual
strains of Escherchia coli in the intestinal tract of man. J. Bacteriol. 63:47–57.
29. Caugant DA, Levin BR, Selander RK. 1981. Genetic diversity and temporal
variation in the E. coli population of a human host. Genetics. 98:467.
30. Damborg P, Nielsen SS, Guardabassi L. 2009. Escherichia coli shedding patterns
in humans and dogs: insights into within-household transmission of phylotypes
associated with urinary tract infections. Epidemiol. Infect. 137:1457–1464.
31. Greenquist MA, Drouillard JS, Sargeant JM, Depenbusch BE, Shi X,
Lechtenberg KF, Nagaraja TG. 2005. Comparison of rectoanal mucosal swab
cultures and fecal cultures for determining prevalence of Escherichia coli O157:H7
in feedlot cattle. Appl. Environ. Microbiol. 71:6431–6433.

32

32. Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O’Bryan TT, Sandberg T.
2005. Phylogenetic and pathotypic comparison of concurrent urine and rectal
Escherichia coli isolates from men with febrile urinary tract infection. J. Clin.
Microbiol. 43:3895–3900.
33. Khaitsa ML, Bauer ML, Gibbs PS, Lardy GP, Doetkott D, Kegode RB. 2005.
Comparison of two sampling methods for Escherichia coli O157:H7 detection in
feedlot cattle. J. Food Prot. 68:1724–1728.
34. Niu YD, Xu Y, McAllister TA, Rozema EA, Stephens TP, Bach SJ, Johnson
RP, Stanford K. 2008. Comparison of fecal versus rectoanal mucosal swab
sampling for detecting Escherichia coli O157:H7 in experimentally inoculated cattle
used in assessing bacteriophage as a mitigation strategy. J. Food Prot. 71:691–698.
35. Black M, Goodman A, Dekhtyar A, Kitts C. 2013. Pyroprinting: a novel strain
differentiation method. unpublished.
36. Montana A, Neal E, Dekhtyar A, Black M, Kitts C. 2011. Chronology-sensitive
hierarchical clustering of pyrosequenced DNA samples of E. coli: a case study.
IEEE International Conference on BIBM. Atlanta, GA.
37. Montana A. 2013. Algorithms for library-based microbial source tracking.
California Polytechnic State University, San Luis Obispo, CA.
38. Colwell R. 2009. EstimateS: Biodiversity Estimation. http://viceroy.eeb.uconn.edu/
estimates/
39. Berg RD. 1996. The indigenous gastrointestinal microflora. Trends Microbiol.
4:430–435.
40. Wallick H, Stuart CA. 1943. Antigenic relationships of Escherichia coli isolated
from one individual. J. Bacteriol. 45:121–126.
41. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR,
Maiden MCJ, Ochman H, Achtman M. 2006. Sex and virulence in Escherichia
coli: an evolutionary perspective. Mol. Microbiol. 60:1136–1151.
42. Johnson JR, Owens K, Gajewski A, Clabots C. 2008. Escherichia coli
colonization patterns among human household members and pets, with attention to
acute urinary tract infection. J. Infect. Dis. 197:218–224.

33

